Guides

Zepbound Pen vs KwikPen: What the Instructions for Use Cover

October 31, 2026

Educational only. Not medical advice. Talk to your doctor.

Short answer: Zepbound® (tirzepatide) is supplied in more than one device, and the two pens are not the same. The single-dose pen is used once and has no separate needle to attach. The KwikPen holds four weekly doses, needs a separate pen needle, and is primed before each injection. This page summarizes what the label and the Instructions for Use (IFU) say, so you know what to expect and what to ask. The IFU that comes with your own device is the final word.

What Zepbound devices does the label list?

Section 16.1 of the Zepbound label on DailyMed (label effective August 28, 2026) lists cartons of four prefilled single-dose pens, one or four single-dose vials, one multi-dose vial, or one single-patient-use KwikPen. Section 2.4 says your prescriber should tell you which presentation you will get and train you on that specific one.

DeviceWhat the label and IFU saySeparate needle or syringe?
Prefilled single-dose pen (autoinjector)One dose per pen, four pens per carton. The IFU has you pull off a gray base cap, place the clear base on your skin, unlock the pen, and press a purple buttonThe IFU lists no needle to attach
Single-dose vialOne dose per vialYes: the label says to use a syringe suited to measuring the dose, and a new syringe and needle each time
Multi-dose vialFour weekly doses per vialYes, same as above
Single-patient-use KwikPenThe IFU: “The Pen contains 4 fixed doses, one dose taken weekly”Yes: the IFU lists a “KwikPen-compatible Pen Needle (not included)”

The Mounjaro® (tirzepatide) label lists the same four presentations. The Wegovy® (semaglutide) label lists single-dose pens, single-dose syringes with integrated needles, and a single-patient-use FlexTouch pen with four weekly doses, plus tablets. Which medicine and which device you receive is up to your prescriber. For how the brands differ, see Ozempic vs Wegovy, Mounjaro vs Zepbound.

How is the KwikPen different from the single-dose pen?

The two IFUs read differently because the devices work differently. The table compares the points each IFU covers.

Single-dose penKwikPen
Doses per deviceOne. Use it, then dispose of the whole penFour fixed doses, one per week. The IFU says the pen “will prevent you from dialing a full dose” after four weekly doses
NeedleBuilt in; pull off the gray base cap and “do not touch the needle”Separate pen needle, new for each injection; screw it on, remove the shields
Before injectingWash hands; check the label, expiration date and that the medicine is clear and colorless to slightly yellowSame checks, plus wipe the red inner seal with an alcohol swab, then prime the pen before each weekly injection
The injectionPlace the clear base flat on skin, turn the lock ring to unlock, press and hold the purple button. A first click means the injection started and a second click means it finished; the gray plunger is visible when doneTurn the dose knob all the way until it stops with the icon in the dose window, insert the needle, push the knob in until it stops and count slowly to five. Confirm the icon is in the dose window
AfterThe whole used pen goes into an FDA-cleared sharps disposal containerReplace the outer needle shield, unscrew the needle into a sharps container, put the pen cap back. Do not store the pen with the needle attached

Quotes and steps are from the Zepbound single-dose pen IFU (revised April 2026) and the multi-dose KwikPen IFU (revised January 2026) on DailyMed. The label’s strengths and the dose each pen delivers are set by your prescriber, so they are not covered here. Follow your own IFU step by step; this table is a map of what it covers, not a replacement.

Where do you inject a Zepbound pen?

The label says to inject under the skin of the abdomen or thigh, or “another person should inject in the back of the upper arm,” and to rotate sites with each dose. The KwikPen IFU adds that the stomach site should be at least 2 inches from the belly button, and that you may use the same area of the body as long as you choose a different spot within it. For the sites in detail, see GLP-1 injection sites.

Who should get help using a pen?

Section 2.4 says that after training, a patient may self-inject if the healthcare provider determines it can be done properly, and that the KwikPen is not recommended for self-administration by people who are visually impaired. The single-dose pen IFU says: “If you have vision problems, do not use your pen without help from a person trained to use the ZEPBOUND pen.” If your prescription changes from one device to another, the label tells prescribers to make sure you get training for the new one and to point you to its IFU.

Both IFUs also say not to share a pen with other people. The KwikPen IFU adds “even if the pen needle has been changed.”

How do you store and throw away the pens?

The details sit in Storing and traveling with GLP-1 pens and GLP-1 pen and needle disposal. The device differences on the label are short:

Single-dose penKwikPen
Refrigerator36°F to 46°F, in the original carton, never frozen36°F to 46°F, in the original carton, never frozen
Out of the fridgeUp to a total of 21 days at up to 86°FUnopened: 30 days at up to 86°F. In use: refrigerated or at room temperature, but throw away after a total of 30 days at room temperature, 30 days after first use, or four weekly doses, “even if there is medicine left in it”
DisposalWhole pen in an FDA-cleared sharps disposal containerNeedle in a sharps container; the IFU says the pen itself can go in household trash or a sharps container once the needle is removed

What if something looks wrong with the pen?

The single-dose pen IFU has a Commonly Asked Questions section. It says air bubbles are normal, that a drop of liquid on the needle tip is normal, and that a drop of liquid or blood on the skin after the injection is normal; press a cotton ball or gauze on the site and do not rub. If you drop the pen on a hard surface, it says not to use it. The KwikPen IFU has a Troubleshooting section for a stuck cap, a hard-to-push dose knob, and a pen that will not turn to the dose position.

For anything that is not clear, the IFU says to call your healthcare provider or Lilly at 1-800-545-5979. Do not guess about a dose that may not have gone in; the IFU and your prescriber decide what happens next.

Does Medicare cover the Zepbound pen?

Under the Medicare GLP-1 Bridge, Medicare.gov says the program covers Zepbound in the KwikPen form only, and that it “doesn’t cover single-dose Zepbound vials or pens.” The rules are dated and change, so check Medicare.gov and see Does Medicare cover GLP-1 drugs?.

How can you keep track?

The KwikPen IFU ends with a medication calendar where you write the day of the week you inject. A simple log with the date, the injection area, and the day you started a new pen helps with the 30-day limit and with appointments. Weeko, a shot tracker coming to iPhone and Android, is being built around that kind of log. It is a logbook, not medical guidance.

When to call your doctor

Ask your prescriber which device you were prescribed and to show you how to use it before your first injection, and again if the device changes. The Medication Guide says to stop using the medicine and call your healthcare provider right away for severe stomach pain that will not go away, and to get medical help right away for signs of a serious allergic reaction such as swelling of the face, lips, tongue or throat, or trouble breathing or swallowing. Tell your provider about a lump or swelling in the neck, hoarseness, or trouble swallowing. If you take too much, call Poison Help at 1-800-222-1222 or go to the nearest emergency room.

Related guides

Sources

  1. Zepbound (tirzepatide) prescribing information, Medication Guide and Instructions for Use, DailyMed
  2. Mounjaro (tirzepatide) prescribing information and Instructions for Use, DailyMed
  3. Wegovy (semaglutide) prescribing information (Section 16, How Supplied), DailyMed
  4. Weight loss drugs, Medicare.gov

Ozempic®, Wegovy®, Rybelsus® are trademarks of Novo Nordisk A/S; Mounjaro®, Zepbound® are trademarks of Eli Lilly and Company. Weeko is not affiliated with or endorsed by these companies.